Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 29  |  Issue : 1  |  Page : 22-29

The role of serum apelin in diabetic patients with retinopathy


1 Internal Medicine Department, Faculty of Medicine, Menoufiya University, Menoufiya, Egypt
2 Internal Medicine Department, Mansoura Insurance Hospital, Mansoura, Egypt

Correspondence Address:
Amany Anwar Mohamed Serag
MBBCh, Biala, 33571 Kafer El-Shiekh
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.178940

Rights and Permissions

Objective The aim of this work is to study serum apelin in patients with diabetic retinopathy and its possible pathophysiological role in such patients. Background Diabetic retinopathy is the most common microvascular complication of diabetes, and it remains a leading cause of blindness and visual impairment in the working-age population in the developed world. Apelin is a peptide isolated from bovine stomach extracts that acts as an endogenous ligand for the previously orphaned G protein-coupled receptors (angiotensin 1-related putative receptors). Apelin has been recognized as a factor promoting angiogenesis, but its role in the development of proliferative diabetic retinopathy (PDR) has not been fully examined. Materials and methods Sixty patients were included in the study and classified into three groups. Group 1, the control group, included individuals without diabetes mellitus (10 patients), group 2 included patients with diabetes mellitus but without retinopathy (20 patients), and group 3 included patients classified into two subgroups: group 3a, which included patients with nonproliferative diabetic retinopathy (NPDR) (15 patients), and group 3b, which included patients with PDR (15 patients). Results Apelin was significantly higher among patients with diabetes without retinopathy, NPDR, and PDR than the control group (P < 0.001); the mean value of apelin was significantly higher in patients with PDR than in those with diabetes without retinopathy (P < 0.05). Also, the mean value of apelin was significantly higher in patients with PDR than NPDR (P < 0.001). Conclusion Serum apelin was significantly higher in patients with PDR compared with those without nonproliferative retinopathy and in those with diabetes without retinopathy, and apelin plays a role in the development of PDR. Ischemic retinopathy could be trated with Inhibition of the apelinergic system. Serum apelin correlated significantly with serum creatinine in patients with retinopathy, which may indicate the role of apelin in diabetic nephropathy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed928    
    Printed16    
    Emailed0    
    PDF Downloaded118    
    Comments [Add]    
    Cited by others 1    

Recommend this journal